Abionyx Pharma (ABNX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 7,843 | 11,141 |
| Other current assets | 1,609 | 2,056 |
| TOTAL | $10,764 | $13,759 |
| Non-Current Assets | ||
| PPE Net | 61 | 150 |
| Intangibles | 0 | 1 |
| Other Non-Current Assets | 12 | 15 |
| TOTAL | $73 | $166 |
| Total Assets | $10,837 | $13,925 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 4,269 | 2,563 |
| Other current liabilities | N/A | 300 |
| TOTAL | $4,701 | $3,079 |
| Non-Current Liabilities | ||
| Long Term Debt | 4,992 | 4,048 |
| Other Non-Current Liabilities | 1,132 | 636 |
| TOTAL | $6,124 | $4,684 |
| Total Liabilities | $10,825 | $7,763 |
| Shareholders' Equity | ||
| Common Shares | 658 | 658 |
| Retained earnings | -117,477 | -111,267 |
| Other shareholders' equity | 47 | -13 |
| TOTAL | $12 | $6,162 |
| Total Liabilities And Equity | $10,837 | $13,925 |